The
peptidoglycan precursor, Lipid II, produced in the model Gram-positive
bacterium Bacillus subtilis differs from Lipid II
found in Gram-negative bacteria such as Escherichia coli by a single amidation on the peptide side chain. How this difference
affects the cross-linking activity of penicillin-binding proteins
(PBPs) that assemble peptidoglycan in cells has not been investigated
because B. subtilis Lipid II was not previously available.
Here we report the synthesis of B. subtilis Lipid
II and its use by purified B. subtilis PBP1 and E. coli PBP1A. While enzymes from both organisms assembled B. subtilis Lipid II into glycan strands, only the B. subtilis enzyme cross-linked the strands. Furthermore, B. subtilis PBP1 catalyzed the exchange of both d-amino acids and d-amino carboxamides into nascent peptidoglycan,
but the E. coli enzyme only exchanged d-amino
acids. We exploited these observations to design a fluorescent d-amino carboxamide probe to label B. subtilis PG in vivo and found that this probe labels the cell wall dramatically
better than existing reagents.